Predictive Biopharmaceutics & Pharmacokinetics
Utilising high-dimensional data modelling and robust physiological mapping to definitively de-risk in vivo performance before clinical exposure.
The Guesswork of Clinical Translation
We do not guess how your molecule will behave; we model it. As your technical co-architects, Dhee Lifesciences constructs highly accurate In Vitro-In Vivo Correlations (IVIVC) and Physiologically Based Pharmacokinetic (PBPK) models. By deeply analysing dissolution profiles, absorption mechanics, and metabolic pathways, we translate bench data into accurate human pharmacokinetic trajectories. This predictive foresight allows us to mathematically optimise the dosage form to achieve the exact target product profile.
Mathematical De-Risking & IVIVC
We do not simply accept a raw molecule; we aggressively interrogate its behaviour. As your technical co-architects, Dhee Lifesciences engineers a bespoke pre-formulation strategy. We conduct exhaustive solid-state characterisation, salt and cocrystal screening, and polymorph evaluation. By mapping the molecule’s pKa, logP, and precise degradation pathways early, we engineer around physical limitations and lock in a highly stable, developable asset ready for complex formulation.
Accelerated by the SynapTx™ AI Ecosystem
Biostatistics require immense computational horsepower. SynapTx™ operates as a dedicated, air-gapped bioinformatics engine, capable of mapping multi-variable PK/PD relationships without risking your proprietary data to the public cloud. By synthesising vast datasets from historical clinical registries and complex pharmacological literature, our local model anticipates ADME (Absorption, Distribution, Metabolism, and Excretion) bottlenecks, providing heavily referenced outputs that guide our formulation strategy.